Owkin: Difference between revisions
Added business details: founded 2016, funding $300M+ |
Added cross-references: AIDAVA Competitive Analysis, AIDAVA Related Companies, Healx |
||
| Line 24: | Line 24: | ||
== See Also == | == See Also == | ||
* [[AIDAVA Competitive Analysis]] | |||
* [[AIDAVA Related Companies]] | |||
* [[Healx]] | |||
* [[Ada Health]] | |||
* [[France]] | * [[France]] | ||
* [[AI Drug Discovery]] | * [[AI Drug Discovery]] | ||
Latest revision as of 17:57, 14 April 2026
What They Do[edit]
AI-powered drug discovery and development platform using federated learning to train models on distributed hospital data without moving patient records.
Funding[edit]
Valuation: $300M+ raised; est. $1B+ valuation $300M+ raised. Backed by GV (Google), Fidelity.
Business Details[edit]
- Founded: 2016
- Total Funding: $300M+
- Valuation: ~$1B+ (est.)
- Revenue: N/A (private)
- Employees: ~300+ (est.)
- Key Milestones: Nature Medicine federated learning research. Partnership with Sanofi. $300M+ raised.